Non-Human Primate Core
非人类灵长类核心
基本信息
- 批准号:7904672
- 负责人:
- 金额:$ 77.62万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-07-15 至 2015-06-30
- 项目状态:已结题
- 来源:
- 关键词:AIDS VaccinesAcquired Immunodeficiency SyndromeAnimal ExperimentationAnimal HousingAnimal ModelAnimalsAnti-Retroviral AgentsAutopsyBloodCaringCell SeparationClinicalClinical ManagementCollaborationsCost SavingsDataDevelopmentEnsureEquipment and supply inventoriesEthicsExperimental DesignsGenetic VariationGoalsHIVHIV-1HousingHumanImmune responseIn Situ HybridizationIn VitroInfectionIntravenousLaboratoriesLeadLightLymphoidLymphoid TissueMacacaMacaca mulattaMarylandModelingMolecularMonitorMononuclearOutcomePathogenesisPerformancePrimatesProceduresProcessProtocols documentationResearchResearch InfrastructureRouteSIVSamplingScheduleServicesSiteSurgical ManagementTestingTissue BanksTissue SampleTrainingUniversitiesVaccine DesignVaccine ResearchVaccinesanimal careanimal facilityanimal resourcedesignexperiencein vivoinsightmeetingsnonhuman primatenovelprogramsresearch studysafety studysample collectiontransmission processvaccine candidate
项目摘要
The development of an effective AIDS vaccine remains one of the highest priorities in HIV research. Studies
of HIV pathogenesis, vaccine design and antiretroviral treatments require the use of an appropriate animal model. However, the currently used SIV/rhesus macaque (RM) model has serious limitations. The overall objective of this HIVRAD proposal is identify and characterize novel, moleculariy defined, physiologically relevant SIVsmm strains that reproducibly lead to productive infection in RMs and more faithfully recapitulate the genetic diversity and the clinical outcome of currently circulating HIV-1 strains. These new challenge strains will also be used to provide new mechanistic insight into mucosal HIV/SIV transmission. The Nonhuman Primate Core located at the University of Pittsburgh will be responsible for managing a large portion
of the primate studies required for this Program Projects. The Specific Aims include:
1. To select, monitor and manage all non-human primates required by Projects 1 and 2. The
goals are to provide these projects with the appropriate animals for the proposed studies, to ensure high quality animal housing and general husbandry, and to perform all aspects of the clinical management of the animals, including the care, treatment and long-term monitoring.
2. To coordinate the design and scheduling of non-human primate studies within the HIVRAD
consortium. The goals are to coordinate the experimental design, arrange for efficient scheduling, collect, process, store and inventory all samples from RMs, and distribute the samples to the research groups.
3. To perform all necropsies required by Projects 1 and 2. The goals are to arrange for tissue
collection, processing and storage, perform mononuclear cell separation from blood, non-lymphoid and lymphoid tissues and conduct all histopathological examinations.
The purpose of the Animal Core Component is to provide high quality of animal care and housing, execution of study protocols, specimen collection and processing, performance of necropsies, and acquisition and management of animal clinical and pathological data necessary to meet the program research objectives. Dr. Pandrea and the Core team will closely interact with Project leaders and their laboratory staff to ensure timely completion of all NHP related research goals.
开发有效的艾滋病疫苗仍然是艾滋病毒研究的最高优先事项之一。研究
HIV发病机制、疫苗设计和抗逆转录病毒治疗的研究需要使用适当的动物模型。然而,目前使用的SIV/恒河猴(RM)模型具有严重的局限性。 HIVRAD 提案的总体目标是识别和表征新型、分子定义的、生理相关的 SIVsmm 毒株,这些毒株可重复地导致 RM 中的生产性感染,并更忠实地再现当前流行的 HIV-1 毒株的遗传多样性和临床结果。这些新的挑战菌株还将用于为粘膜 HIV/SIV 传播提供新的机制见解。位于匹兹堡大学的非人类灵长类动物核心将负责管理很大一部分
本计划项目所需的灵长类动物研究。具体目标包括:
1. 选择、监测和管理项目1和2所需的所有非人灵长类动物。
目标是为这些项目提供适合拟议研究的动物,确保高质量的动物饲养和一般饲养,并执行动物临床管理的各个方面,包括护理、治疗和长期监测。
2. 协调 HIVRAD 内非人类灵长类动物研究的设计和安排
财团。目标是协调实验设计,安排有效的调度,收集、处理、存储和库存来自 RM 的所有样本,并将样本分发给研究小组。
3. 进行项目 1 和 2 所需的所有尸检。目标是安排组织
收集、处理和储存,从血液、非淋巴和淋巴组织中分离单核细胞,并进行所有组织病理学检查。
动物核心部分的目的是提供高质量的动物护理和饲养、研究方案的执行、标本采集和处理、尸检的进行以及满足项目研究目标所需的动物临床和病理数据的采集和管理。 Pandrea 博士和核心团队将与项目负责人及其实验室工作人员密切互动,以确保及时完成所有 NHP 相关研究目标。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ivona Vasile Pandrea其他文献
Ivona Vasile Pandrea的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ivona Vasile Pandrea', 18)}}的其他基金
Probing the role of adenosine pathway in SIV pathogenesis
探讨腺苷途径在 SIV 发病机制中的作用
- 批准号:
10760676 - 财政年份:2023
- 资助金额:
$ 77.62万 - 项目类别:
Mechanistic Studies of Gut Dysfunction Exacerbation due to SARS-CoV-2 in HIV/SIV infected Individuals
HIV/SIV 感染者中 SARS-CoV-2 导致肠道功能恶化的机制研究
- 批准号:
10452676 - 财政年份:2021
- 资助金额:
$ 77.62万 - 项目类别:
Mechanistic Studies of Gut Dysfunction Exacerbation due to SARS-CoV-2 in HIV/SIV infected Individuals
HIV/SIV 感染者中 SARS-CoV-2 导致肠道功能恶化的机制研究
- 批准号:
10319695 - 财政年份:2021
- 资助金额:
$ 77.62万 - 项目类别:
Mechanistic Studies of Gut Dysfunction Exacerbation due to SARS-CoV-2 in HIV/SIV infected Individuals
HIV/SIV 感染者中 SARS-CoV-2 导致肠道功能恶化的机制研究
- 批准号:
10622542 - 财政年份:2021
- 资助金额:
$ 77.62万 - 项目类别:
Interventions to Reduce Hypercoagulability in Old SIV-Infected NHPs
降低感染 SIV 的旧 NHP 的高凝状态的干预措施
- 批准号:
8983585 - 财政年份:2015
- 资助金额:
$ 77.62万 - 项目类别:
Impact of NETosis on SIV Pathogenesis and Response to Treatment
NETosis 对 SIV 发病机制和治疗反应的影响
- 批准号:
10666361 - 财政年份:2015
- 资助金额:
$ 77.62万 - 项目类别:
Interventions to Reduce Hypercoagulability in Old SIV-Infected NHPs
降低感染 SIV 的旧 NHP 的高凝状态的干预措施
- 批准号:
9307988 - 财政年份:2015
- 资助金额:
$ 77.62万 - 项目类别:
Impact of NETosis on SIV Pathogenesis and Response to Treatment
NETosis 对 SIV 发病机制和治疗反应的影响
- 批准号:
10666361 - 财政年份:2015
- 资助金额:
$ 77.62万 - 项目类别:
Impact of NETosis on SIV Pathogenesis and Response to Treatment
NETosis 对 SIV 发病机制和治疗反应的影响
- 批准号:
10402152 - 财政年份:2015
- 资助金额:
$ 77.62万 - 项目类别:
Interventions to Reduce Hypercoagulability in Old SIV-Infected NHPs
降低感染 SIV 的旧 NHP 的高凝状态的干预措施
- 批准号:
9108998 - 财政年份:2015
- 资助金额:
$ 77.62万 - 项目类别:
相似国自然基金
从CD4+、CD8+T细胞免疫活化分子及其上游调控因子表达探究健脾祛湿法治疗艾滋病免疫调节机制
- 批准号:81460716
- 批准年份:2014
- 资助金额:48.0 万元
- 项目类别:地区科学基金项目
HAART过程中HCV复制增强与肝细胞MAVS抗病毒通路的关系研究
- 批准号:81201286
- 批准年份:2012
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Generation of Genotypically Diverse R5 SHIVs as Tools in HIV-1 Vaccine Research
生成基因型多样化的 R5 SHIV 作为 HIV-1 疫苗研究的工具
- 批准号:
8845512 - 财政年份:2014
- 资助金额:
$ 77.62万 - 项目类别:
Generation of Genotypically Diverse R5 SHIVs as Tools in HIV-1 Vaccine Research
生成基因型多样化的 R5 SHIV 作为 HIV-1 疫苗研究的工具
- 批准号:
8730833 - 财政年份:2014
- 资助金额:
$ 77.62万 - 项目类别:
ESTABLISHMENT OF SPECIFIC PATHOGEN FREE RHESUS AND PIGTAIL MACAQUE COLONIES
无特定病原体的恒河猴和尾猴群体的建立
- 批准号:
7958424 - 财政年份:2009
- 资助金额:
$ 77.62万 - 项目类别:
ESTABLISHMENT OF SPECIFIC PATHOGEN FREE RHESUS MACAQUE COLONIES
无特定病原体的恒河猴群体的建立
- 批准号:
7958411 - 财政年份:2009
- 资助金额:
$ 77.62万 - 项目类别: